217 related articles for article (PubMed ID: 27857050)
1. Central nervous system lymphoma: a morphological MRI study.
Koubska E; Weichet J; Malikova H
Neuro Endocrinol Lett; 2016 Sep; 37(4):318-324. PubMed ID: 27857050
[TBL] [Abstract][Full Text] [Related]
2. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
3. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features.
Sutherland T; Yap K; Liew E; Tartaglia C; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Jun; 56(3):295-301. PubMed ID: 22697326
[TBL] [Abstract][Full Text] [Related]
5. MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients.
Schulte-Altedorneburg G; Heuser L; Pels H
Eur J Radiol; 2012 Sep; 81(9):2380-5. PubMed ID: 21683538
[TBL] [Abstract][Full Text] [Related]
6. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma.
Abe Y; Narita K; Kobayashi H; Kitadate A; Takeuchi M; Kikuchi Y; Ouchi T; Takeuchi K; Matsue K
Ann Hematol; 2018 Dec; 97(12):2345-2352. PubMed ID: 30141061
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective study of 48 cases of primary central nervous system lymphoma].
Alessandro L; Pastor Rueda JM; Villalonga JF; Bruno VA; Carpani F; Blaquier JB; Tognarelli S; Varela FJ; Muggeri A
Medicina (B Aires); 2017; 77(1):17-23. PubMed ID: 28140306
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.
O'Connor T; Zhou X; Kosla J; Adili A; Garcia Beccaria M; Kotsiliti E; Pfister D; Johlke AL; Sinha A; Sankowski R; Schick M; Lewis R; Dokalis N; Seubert B; Höchst B; Inverso D; Heide D; Zhang W; Weihrich P; Manske K; Wohlleber D; Anton M; Hoellein A; Seleznik G; Bremer J; Bleul S; Augustin HG; Scherer F; Koedel U; Weber A; Protzer U; Förster R; Wirth T; Aguzzi A; Meissner F; Prinz M; Baumann B; Höpken UE; Knolle PA; von Baumgarten L; Keller U; Heikenwalder M
Cancer Cell; 2019 Sep; 36(3):250-267.e9. PubMed ID: 31526758
[TBL] [Abstract][Full Text] [Related]
10. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.
Coulon A; Lafitte F; Hoang-Xuan K; Martin-Duverneuil N; Mokhtari K; Blustajn J; Chiras J
Eur Radiol; 2002 Feb; 12(2):329-40. PubMed ID: 11870430
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance as initial screening diagnosis of secondary involvement of central nervous system in NHL diffuse large B cell lymphoma].
Oliver AC; Irigoin V; Sgarbi N; Peixoto A; Turcatti P; Diaz L; Zunino J
Rev Fac Cien Med Univ Nac Cordoba; 2018 Jun; 75(2):67-71. PubMed ID: 30273529
[TBL] [Abstract][Full Text] [Related]
12. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography combined with computed tomography in the initial evaluation and response assessment in primary central nervous system lymphoma].
Mercadal S; Cortés-Romera M; Vélez P; Climent F; Gámez C; González-Barca E
Med Clin (Barc); 2015 Jun; 144(11):503-6. PubMed ID: 25433778
[TBL] [Abstract][Full Text] [Related]
15. Secondary central nervous system lymphoma: spectrum of morphological MRI appearances.
Malikova H; Burghardtova M; Koubska E; Mandys V; Kozak T; Weichet J
Neuropsychiatr Dis Treat; 2018; 14():733-740. PubMed ID: 29559780
[TBL] [Abstract][Full Text] [Related]
16. [Primary lymphoma of the central nervous system in immunocompetent patients: neuroimaging features].
Sobrido-Sampedro C; Corroto JD; Arias-González M; Corroto-Murúa J; Pumar JM
Rev Neurol; 2012 Oct; 55(8):462-8. PubMed ID: 23055427
[TBL] [Abstract][Full Text] [Related]
17. Tumor Vascular Permeability Pattern Is Associated With Complete Response in Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: Retrospective Cohort Study.
Chung SR; Choi YJ; Kim HS; Park JE; Shim WH; Kim SJ
Medicine (Baltimore); 2016 Feb; 95(6):e2624. PubMed ID: 26871782
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatous involvement of the central nervous system.
Bathla G; Hegde A
Clin Radiol; 2016 Jun; 71(6):602-9. PubMed ID: 27038652
[TBL] [Abstract][Full Text] [Related]
19. Incidence and radiographic findings of primary central nervous system lymphoma in immunocompetent patients in southern Thailand.
Rujirojindakul P; Rohitoprakarn M; Kongkabpan D; Viboonjantra P; Lekhakula A
Tumori; 2008; 94(3):304-8. PubMed ID: 18705395
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
